Jeff King, a 63-year-old pastor from Lawrence, Kansas, underwent a heart ablation and was billed around $160,000 after his cost‑sharing plan declined to cover a pre‑existing condition. His case, reported by NPR’s Midwest partner, mirrors a wider pattern: KFF estimates roughly 100 million adults in the US carry medical or dental debt. (kcur.org)
The cost backdrop is unmissable. CMS puts 2024 national health spending at $5.3 trillion and projects further growth, with analysts estimating the total will approach $5.9 trillion in 2026. The US continues to spend nearly twice as much per person as peer nations while scoring worse on key outcomes, according to the Peterson‑KFF Health System Tracker and the Commonwealth Fund’s 2024 comparative assessment. (cms.gov)
A pivotal driver of 2026 affordability pressures is the expiry of the enhanced Affordable Care Act premium tax credits on 31 December 2025. KFF’s modelling indicates average net premiums for subsidised marketplace enrollees rise by 114% this year without an extension. Individual stories, such as Utah small‑business owner Stacy Cox facing a quoted increase from roughly $495 to $2,169 a month, underline the scale of the shift. (kff.org)
Congress has moved unevenly. On 8 January 2026, the US House approved a bill to restore enhanced ACA assistance; in parallel, stand‑alone measures to extend the credits for 2026 were introduced in the House. Negotiations in the Senate have since faltered, leaving consumers exposed as enrolment decisions lock in. (theguardian.com)
The White House has set out an alternative framing under its ‘Great Healthcare Plan’, pledging to send money directly to eligible households to buy coverage, clamp down on broker and PBM “kickbacks”, and require clearer information on denial rates and claims payments. The published material outlines the direction but does not specify funding levels or the value of proposed direct payments. (whitehouse.gov)
Drug pricing is being pursued on two tracks. On 5–6 February 2026, the Administration launched TrumpRx.gov to route patients (especially the uninsured) to manufacturer discounts pegged to ‘most‑favoured‑nation’ prices for a limited set of medicines. In parallel, the Inflation Reduction Act’s Medicare negotiation process has set Maximum Fair Prices for an initial 10 high‑spend Part D drugs effective from 1 January 2026, with further rounds scheduled. (whitehouse.gov)
CMS says the negotiated Part D prices would have saved Medicare an estimated $6bn had they been in force in 2023, with beneficiary out‑of‑pocket savings expected in 2026. CMS has since selected additional medicines for future negotiation cycles, including - for the first time - certain Part B drugs, with prices due to take effect in 2028. (cms.gov)
Cover remains hard to use. KFF’s analysis of HealthCare.gov data shows about one in five in‑network claims were denied in 2023, while Commonwealth Fund survey work finds 17% of insured working‑age adults had coverage denied for clinician‑recommended care, often resulting in delays. Low appeal rates compound the effect. (techtarget.com)
Credit reporting reform has been uneven. The Consumer Financial Protection Bureau finalised a rule in January 2025 to remove medical bills from credit reports used by lenders, but a federal court later set it aside; several states have enacted their own bans, including New York and California, limiting the use of medical debt in credit files. (consumerfinance.gov)
Many households have looked beyond traditional cover to health care sharing ministries. Regulators caution these arrangements are not insurance, carry no payment guarantee, and lack ACA protections on pre‑existing conditions and essential benefits. Consumers are urged to read disclosures carefully before joining. (michigan.gov)
Public anger over affordability has spilled into courtrooms. Following the December 2024 killing of UnitedHealthcare’s chief executive, supporters of the accused, Luigi Mangione, have gathered outside hearings with ‘Free Luigi’ slogans; on 30 January 2026 a federal judge dismissed charges that would have allowed the death penalty, leaving federal stalking counts and state murder proceedings to continue. (theguardian.com)
For households, the immediate calculus is practical. Unless Congress acts, average net marketplace premiums rise sharply in 2026; KFF and CBO‑referenced analysis suggests millions more could become uninsured. State‑level subsidies can soften the blow in some jurisdictions - for example New Jersey’s programme - but cannot replicate the federal expansion on scale. (kff.org)